First PREMIER Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $177K | Sell |
3,066
-37
| -1% | -$2.13K | 0.03% | 178 |
|
|
2026
Q1 | $188K | Sell |
3,103
-171
| -5% | -$9.97K | 0.04% | 167 |
|
|
2025
Q4 | $176K | Hold |
3,274
| – | – | 0.04% | 167 |
|
|
2025
Q3 | $148K | Hold |
3,274
| – | – | 0.03% | 177 |
|
|
2025
Q2 | $152K | Sell |
3,274
-805
| -20% | -$39.5K | 0.04% | 171 |
|
|
2025
Q1 | $249K | Hold |
4,079
| – | – | 0.06% | 131 |
|
|
2024
Q4 | $231K | Hold |
4,079
| – | – | 0.06% | 141 |
|
|
2024
Q3 | $211K | Sell |
4,079
-2,678
| -40% | -$126K | 0.05% | 148 |
|
|
2024
Q2 | $280K | Sell |
6,757
-3,573
| -35% | -$160K | 0.07% | 125 |
|
|
2024
Q1 | $561K | Sell |
10,330
-585
| -5% | -$29.8K | 0.15% | 103 |
|
|
2023
Q4 | $560K | Sell |
10,915
-288
| -3% | -$15.1K | 0.16% | 100 |
|
|
2023
Q3 | $674K | Sell |
11,203
-505
| -4% | -$30.9K | 0.21% | 88 |
|
|
2023
Q2 | $749K | Sell |
11,708
-2,745
| -19% | -$184K | 0.21% | 87 |
|
|
2023
Q1 | $1M | Sell |
14,453
-50
| -0.3% | -$3.53K | 0.29% | 73 |
|
|
2022
Q4 | $1.04M | Sell |
14,503
-75
| -0.5% | -$5.66K | 0.32% | 69 |
|
|
2022
Q3 | $1.03M | Buy |
14,578
+110
| +0.8% | +$7.98K | 0.34% | 67 |
|
|
2022
Q2 | $1.11M | Sell |
14,468
-482
| -3% | -$36.7K | 0.33% | 67 |
|
|
2022
Q1 | $1.09M | Buy |
14,950
+937
| +7% | +$62.9K | 0.29% | 73 |
|
|
2021
Q4 | $873K | Sell |
14,013
-195
| -1% | -$11.4K | 0.23% | 85 |
|
|
2021
Q3 | $840K | Buy |
14,208
+745
| +6% | +$49.1K | 0.24% | 85 |
|
|
2021
Q2 | $900K | Buy |
13,463
+1,070
| +9% | +$69.8K | 0.26% | 79 |
|
|
2021
Q1 | $782K | Hold |
12,393
| – | – | 0.28% | 80 |
|
|
2020
Q4 | $769K | Buy |
12,393
+3,103
| +33% | +$191K | 0.31% | 71 |
|
|
2020
Q3 | $560K | Buy |
9,290
+70
| +0.8% | +$4.21K | 0.25% | 77 |
|
|
2020
Q2 | $542K | Buy |
9,220
+550
| +6% | +$32.9K | 0.26% | 75 |
|
|
2020
Q1 | $483K | Hold |
8,670
| – | – | 0.27% | 79 |
|
|
2019
Q4 | $557K | Buy |
8,670
+243
| +3% | +$13.9K | 0.26% | 83 |
|
|
2019
Q3 | $427K | Sell |
8,427
-200
| -2% | -$9.4K | 0.22% | 85 |
|
|
2019
Q2 | $392K | Sell |
8,627
-200
| -2% | -$9.32K | 0.21% | 85 |
|
|
2019
Q1 | $421K | Buy |
8,827
+1,370
| +18% | +$68.2K | 0.24% | 81 |
|
|
2018
Q4 | $387K | Buy |
7,457
+200
| +3% | +$10.7K | 0.25% | 80 |
|
|
2018
Q3 | $451K | Buy |
7,257
+75
| +1% | +$4.45K | 0.28% | 73 |
|
|
2018
Q2 | $398K | Buy |
7,182
+465
| +7% | +$25.1K | 0.27% | 74 |
|
|
2018
Q1 | $425K | Buy |
6,717
+450
| +7% | +$28.9K | 0.31% | 67 |
|
|
2017
Q4 | $384K | Sell |
6,267
-190
| -3% | -$11.9K | 0.26% | 75 |
|
|
2017
Q3 | $412K | Buy |
6,457
+680
| +12% | +$39.7K | 0.29% | 69 |
|
|
2017
Q2 | $322K | Sell |
5,777
-874
| -13% | -$47.6K | 0.24% | 72 |
|
|
2017
Q1 | $362K | Buy |
6,651
+833
| +14% | +$45.7K | 0.27% | 69 |
|
|
2016
Q4 | $340K | Hold |
5,818
| – | – | 0.26% | 67 |
|
|
2016
Q3 | $314K | Buy |
5,818
+200
| +4% | +$12.8K | 0.24% | 73 |
|
|
2016
Q2 | $413K | Sell |
5,618
-70
| -1% | -$4.95K | 0.31% | 57 |
|
|
2016
Q1 | $363K | Buy |
5,688
+160
| +3% | +$10.1K | 0.29% | 60 |
|
|
2015
Q4 | $380K | Buy |
+5,528
| New | +$365K | 0.32% | 57 |
|
Other funds holding BMY
First PREMIER Bank's BMY Position: Q2 2026 in Review
First PREMIER Bank reduced its Bristol-Myers Squibb (BMY) stake by 1.2% in Q2 2026, selling an estimated $2.13K and leaving 3,066 shares worth $177K. The position accounts for 0.03% of the portfolio, ranked #178.
First PREMIER Bank first reported a position in BMY in Q4 2015 and has held it in 43 quarters since. The position peaked at $1.11M in Q2 2022. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- First PREMIER Bank held 3,066 shares of Bristol-Myers Squibb worth $177K as of Q2 2026.
- First PREMIER Bank sold 37 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.13K.
- Bristol-Myers Squibb made up 0.03% of First PREMIER Bank's portfolio in Q2 2026, its #178 holding.
- First PREMIER Bank first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 43 quarters since.
- First PREMIER Bank's Bristol-Myers Squibb position peaked at $1.11M in Q2 2022.
- 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on First PREMIER Bank's 13F filing for Q2 2026, filed 15 Jul 2026.